Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis.

Author: Jae Hyun KIM ¹ ; Jae Hee CHEON
Author Information

1. Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. geniushee@yuhs.ac
Publication Type:Comment ; Editorial
MeSH: *Adalimumab; Antibodies, Monoclonal, Humanized/therapeutic use; Colitis, Ulcerative/*drug therapy; Humans; Remission Induction
From:Gut and Liver 2016;10(2):162-163
CountryRepublic of Korea
Language:English
Abstract: No abstract available.